| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 294 | 196.045 | 58.283 | 35.322 | 65.324 | 38.017 | 51.366 |
| Total Income - EUR | - | - | - | 294 | 196.045 | 58.283 | 35.328 | 65.324 | 38.019 | 51.366 |
| Total Expenses - EUR | - | - | - | 814 | 4.957 | 13.393 | 14.804 | 14.851 | 27.960 | 17.897 |
| Gross Profit/Loss - EUR | - | - | - | -520 | 191.088 | 44.890 | 20.524 | 50.473 | 10.059 | 33.469 |
| Net Profit/Loss - EUR | - | - | - | -529 | 186.260 | 43.478 | 19.693 | 49.441 | 9.687 | 32.966 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Oriapmed X S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 28.197 | 19.567 | 11.622 | 0 | 558 |
| Current Assets | - | - | - | 337 | 192.767 | 73.180 | 47.933 | 67.331 | 42.653 | 41.869 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 294 | 120.398 | 67.396 | 31.054 | 46.323 | 8 | 22.552 |
| Cash | - | - | - | 43 | 72.369 | 5.783 | 16.879 | 21.007 | 42.646 | 19.316 |
| Shareholders Funds | - | - | - | -486 | 185.784 | 89.294 | 60.193 | 49.489 | 35.079 | 33.014 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 822 | 6.983 | 12.082 | 7.307 | 29.463 | 7.575 | 9.413 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Oriapmed X S.r.l.